← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Camden National grew FY2025 net income 22.9% and equity 31.1%, helped by the Northway acquisition and higher fee rows.
The read at a glance✓ Audited against SEC data
- Business mix — Northern New England bankNote
- Assets — $7.0BOK
- Revenue row — $41.7M, +17.0%OK
- Net income — $65.2M, +22.9%OK
- Equity — $696.6M, +31.1%OK
- Insiders — 0 purchases / 0 salesNote
- Accounting — Bank screen unavailableNote
Business
Camden National is a Maine bank holding company for Camden National Bank, serving consumers, businesses, nonprofits, municipalities, and wealth clients.
Where the revenue comes from
Fiscal 2025, as CAMDEN NATIONAL CORP reports it. History and quarterly detail are in the app.
- Debit card income$15.3M
- Debit Card$15.3M
- Service charges on deposit accounts$9.9M
- Deposit Accounts$9.9M
- Income from fiduciary services$7.6M
Leadership changes
From CAMDEN NATIONAL CORP's own filings, the day they're filed.
- Larry K. Haynes · director · appointmenteff. 2025-01-01
- Simon Griffiths · Chief Operating Officer · appointmenteff. 2024-01-01
- Ryan Smith · President · departureeff. 2023-12-12
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-06
- 8-K · Company announcement2026-06-30
- 8-K · Company announcement2026-06-18
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CAMDEN NATIONAL CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.